VC
Vivo Capital’s Aligos Therapeutics ALGS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,199
| Closed | -$84.1K | – | 43 |
|
2025
Q1 | $84.1K | Sell |
10,199
-131,680
| -93% | -$1.09M | 0.01% | 39 |
|
2024
Q4 | $5.65M | Hold |
141,879
| – | – | 0.63% | 32 |
|
2024
Q3 | $1.23M | Sell |
141,879
-3,405,151
| -96% | -$29.5M | 0.1% | 38 |
|
2024
Q2 | $1.24M | Hold |
3,547,030
| – | – | 0.11% | 36 |
|
2024
Q1 | $3.48M | Hold |
3,547,030
| – | – | 0.27% | 38 |
|
2023
Q4 | $2.36M | Hold |
3,547,030
| – | – | 0.19% | 43 |
|
2023
Q3 | $2.65M | Hold |
3,547,030
| – | – | 0.29% | 43 |
|
2023
Q2 | $3.44M | Hold |
3,547,030
| – | – | 0.24% | 41 |
|
2023
Q1 | $3.1M | Hold |
3,547,030
| – | – | 0.22% | 38 |
|
2022
Q4 | $3.38M | Hold |
3,547,030
| – | – | 0.39% | 39 |
|
2022
Q3 | $3.9M | Hold |
3,547,030
| – | – | 0.43% | 42 |
|
2022
Q2 | $4.29M | Hold |
3,547,030
| – | – | 0.43% | 40 |
|
2022
Q1 | $7.63M | Hold |
3,547,030
| – | – | 0.53% | 36 |
|
2021
Q4 | $42.1M | Hold |
3,547,030
| – | – | 2.54% | 9 |
|
2021
Q3 | $55M | Hold |
3,547,030
| – | – | 2.47% | 10 |
|
2021
Q2 | $72.3M | Hold |
3,547,030
| – | – | 3.13% | 9 |
|
2021
Q1 | $80.7M | Hold |
3,547,030
| – | – | 2.83% | 10 |
|
2020
Q4 | $98.1M | Buy |
+3,547,030
| New | +$98.1M | 4.38% | 6 |
|